List of Contents

Respiratory Disease Vaccine Market Size, Share, and Trends 2025 to 2034

The global respiratory disease vaccine market size accounted for USD 101.1 billion in 2025 and is projected to surpass around USD 121.36 billion by 2034, representing a healthy CAGR of 2.05% between 2025 and 2034. The Asia Pacific respiratory disease vaccine market size accounted for USD 34.37 billion in 2025 and is expanding at a CAGR of 2.20% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : May 2025
  • Report Code : 3249
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Respiratory Disease Vaccine Market 

5.1. COVID-19 Landscape: Respiratory Disease Vaccine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Respiratory Disease Vaccine Market, By Disease Type

8.1. Respiratory Disease Vaccine Market Revenue and Volume, by Disease Type

8.1.1. Chronic Obstructive Pulmonary Disease (COPD)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Pertussis

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Pneumonia

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Measles

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Diphtheria

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Respiratory Disease Vaccine Market, By Type

9.1. Respiratory Disease Vaccine Market Revenue and Volume, by Type

9.1.1. Viral Vaccine

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Bacterial Vaccine

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Combination Vaccine

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Respiratory Disease Vaccine Market, By Age Group 

10.1. Respiratory Disease Vaccine Market Revenue and Volume, by Age Group

10.1.1. Pediatric

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Adult

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Respiratory Disease Vaccine Market, By Infection

11.1. Respiratory Disease Vaccine Market Revenue and Volume, by Infection

11.1.1. COVID-19

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Influenza

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Respiratory Syncytial Virus (RSV)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Pneumonia

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Respiratory Disease Vaccine Market, By Distribution Channel

12.1. Respiratory Disease Vaccine Market Revenue and Volume, by Distribution Channel

12.1.1. Hospital & Retail Pharmacies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Government Suppliers

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Others

12.1.3.1. Market Revenue and Volume Forecast

Chapter 13. Global Respiratory Disease Vaccine Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Disease Type

13.1.2. Market Revenue and Volume Forecast, by Type

13.1.3. Market Revenue and Volume Forecast, by Age Group

13.1.4. Market Revenue and Volume Forecast, by Infection

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Disease Type

13.1.6.2. Market Revenue and Volume Forecast, by Type

13.1.6.3. Market Revenue and Volume Forecast, by Age Group

13.1.6.4. Market Revenue and Volume Forecast, by Infection

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Disease Type

13.1.7.2. Market Revenue and Volume Forecast, by Type

13.1.7.3. Market Revenue and Volume Forecast, by Age Group

13.1.7.4. Market Revenue and Volume Forecast, by Infection

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Disease Type

13.2.2. Market Revenue and Volume Forecast, by Type

13.2.3. Market Revenue and Volume Forecast, by Age Group

13.2.4. Market Revenue and Volume Forecast, by Infection  

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Disease Type

13.2.6.2. Market Revenue and Volume Forecast, by Type

13.2.6.3. Market Revenue and Volume Forecast, by Age Group

13.2.7. Market Revenue and Volume Forecast, by Infection  

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Disease Type

13.2.9.2. Market Revenue and Volume Forecast, by Type

13.2.9.3. Market Revenue and Volume Forecast, by Age Group

13.2.10. Market Revenue and Volume Forecast, by Infection

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Disease Type

13.2.12.2. Market Revenue and Volume Forecast, by Type

13.2.12.3. Market Revenue and Volume Forecast, by Age Group

13.2.12.4. Market Revenue and Volume Forecast, by Infection

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Disease Type

13.2.14.2. Market Revenue and Volume Forecast, by Type

13.2.14.3. Market Revenue and Volume Forecast, by Age Group

13.2.14.4. Market Revenue and Volume Forecast, by Infection

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Disease Type

13.3.2. Market Revenue and Volume Forecast, by Type

13.3.3. Market Revenue and Volume Forecast, by Age Group

13.3.4. Market Revenue and Volume Forecast, by Infection

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Disease Type

13.3.6.2. Market Revenue and Volume Forecast, by Type

13.3.6.3. Market Revenue and Volume Forecast, by Age Group

13.3.6.4. Market Revenue and Volume Forecast, by Infection

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Disease Type

13.3.8.2. Market Revenue and Volume Forecast, by Type

13.3.8.3. Market Revenue and Volume Forecast, by Age Group

13.3.8.4. Market Revenue and Volume Forecast, by Infection

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Disease Type

13.3.10.2. Market Revenue and Volume Forecast, by Type

13.3.10.3. Market Revenue and Volume Forecast, by Age Group

13.3.10.4. Market Revenue and Volume Forecast, by Infection

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Disease Type

13.3.11.2. Market Revenue and Volume Forecast, by Type

13.3.11.3. Market Revenue and Volume Forecast, by Age Group

13.3.11.4. Market Revenue and Volume Forecast, by Infection

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Disease Type

13.4.2. Market Revenue and Volume Forecast, by Type

13.4.3. Market Revenue and Volume Forecast, by Age Group

13.4.4. Market Revenue and Volume Forecast, by Infection

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Disease Type

13.4.6.2. Market Revenue and Volume Forecast, by Type

13.4.6.3. Market Revenue and Volume Forecast, by Age Group

13.4.6.4. Market Revenue and Volume Forecast, by Infection

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Disease Type

13.4.8.2. Market Revenue and Volume Forecast, by Type

13.4.8.3. Market Revenue and Volume Forecast, by Age Group

13.4.8.4. Market Revenue and Volume Forecast, by Infection

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Disease Type

13.4.10.2. Market Revenue and Volume Forecast, by Type

13.4.10.3. Market Revenue and Volume Forecast, by Age Group

13.4.10.4. Market Revenue and Volume Forecast, by Infection

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Disease Type

13.4.11.2. Market Revenue and Volume Forecast, by Type

13.4.11.3. Market Revenue and Volume Forecast, by Age Group

13.4.11.4. Market Revenue and Volume Forecast, by Infection

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Disease Type

13.5.2. Market Revenue and Volume Forecast, by Type

13.5.3. Market Revenue and Volume Forecast, by Age Group

13.5.4. Market Revenue and Volume Forecast, by Infection

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Disease Type

13.5.6.2. Market Revenue and Volume Forecast, by Type

13.5.6.3. Market Revenue and Volume Forecast, by Age Group

13.5.6.4. Market Revenue and Volume Forecast, by Infection

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Disease Type

13.5.8.2. Market Revenue and Volume Forecast, by Type

13.5.8.3. Market Revenue and Volume Forecast, by Age Group

13.5.8.4. Market Revenue and Volume Forecast, by Infection

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. Sanofi

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. GSK plc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Merck & Co., Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Pfizer Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bavarian Nordic

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. EMERGENT

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. CSL Limited

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Moderna, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Serum Institute of India Pvt. Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Sinovac Biotech

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global respiratory disease vaccine market size is expected to increase USD 121.36 billion by 2034 from USD 99.07 billion in 2024.

The global respiratory disease vaccine market will register growth rate of 2.05% between 2025 and 2034.

The major players operating in the respiratory disease vaccine market are Sanofi, GSK plc, Merck & Co., Inc., Pfizer Inc., Bavarian Nordic, EMERGENT, CSL Limited, Moderna, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech, and Others.

The driving factors of the respiratory disease vaccine market are the rising burden of respiratory diseases and integration of mRNA vaccines.

North America region will lead the global respiratory disease vaccine market during the forecast period 2025 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us